Association between variants in TCF7L2 , CTRB1/2 , and GLP-1R genes and response to therapy with glucagon-like peptide-1 receptor agonists.

MLA

Kyriakidou, Artemis, et al. “Association between Variants in TCF7L2 , CTRB1/2 , and GLP-1R Genes and Response to Therapy with Glucagon-like Peptide-1 Receptor Agonists.” Postgraduate Medicine, vol. 136, no. 2, Mar. 2024, pp. 218–25. EBSCOhost, https://doi.org/10.1080/00325481.2024.2328513.

APA

Kyriakidou, A., Kyriazou, A. V., Koufakis, T., Vasilopoulos, Y., Avramidis, I., Baltagiannis, S., Goulis, D. G., & Kotsa, K. (2024). Association between variants in TCF7L2 , CTRB1/2 , and GLP-1R genes and response to therapy with glucagon-like peptide-1 receptor agonists. Postgraduate Medicine, 136(2), 218–225. https://doi.org/10.1080/00325481.2024.2328513

Chicago

Kyriakidou, Artemis, Angeliki V Kyriazou, Theocharis Koufakis, Yiannis Vasilopoulos, Iakovos Avramidis, Stefanos Baltagiannis, Dimitrios G Goulis, and Kalliopi Kotsa. 2024. “Association between Variants in TCF7L2 , CTRB1/2 , and GLP-1R Genes and Response to Therapy with Glucagon-like Peptide-1 Receptor Agonists.” Postgraduate Medicine 136 (2): 218–25. doi:10.1080/00325481.2024.2328513.